TPF
ABBV icon

Tribridge Partners Financial’s AbbVie ABBV Stock Holding History

Tribridge Partners Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$270K Buy
1,294
+118
+10% +$26.2K 0.11% 64
2025
Q4 		$269K Hold
1,176
– – 0.11% 58
2025
Q3 		$278K Hold
1,176
– – 0.13% 53
2025
Q2 		$218K Buy
+1,176
New +$219K 0.13% 55

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tribridge Partners Financial's ABBV Position: Q1 2026 in Review

Tribridge Partners Financial increased its AbbVie (ABBV) stake by 10% in Q1 2026, buying an estimated $26.2K and bringing the position to 1,294 shares worth $270K. The position accounts for 0.11% of the portfolio, ranked #64.

Tribridge Partners Financial first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. The position peaked at $278K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Tribridge Partners Financial held 1,294 shares of AbbVie worth $270K as of Q1 2026.
  • Tribridge Partners Financial bought 118 AbbVie shares in Q1 2026, an estimated $26.2K.
  • AbbVie made up 0.11% of Tribridge Partners Financial's portfolio in Q1 2026, its #64 holding.
  • Tribridge Partners Financial first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
  • Tribridge Partners Financial's AbbVie position peaked at $278K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Tribridge Partners Financial's 13F filing for Q1 2026, filed 15 Apr 2026.